بررسی عوامل بالینی مرتبط با تأخیر در درمان اولین علائم روان‌پریشی بیماران مراجعه کننده به بیمارستان فارابی کرمانشاه

نوع مقاله : مقاله پژوهشی

نویسندگان

1 دانشجوی دکتری تخصصی روانشناسی سلامت، گروه روان‌شناسی سلامت، واحد کرج، دانشگاه آزاد اسلامی، کرج، ایران.

2 استاد تمام گروه روانشناسی ، گروه روانشناسی سلامت، واحدکرج، دانشگاه آزاد اسلامی، کرج، ایران

3 دانشیار گروه روان‌پزشکی، دانشکده پزشکی، دانشگاه علوم پزشکی کرمانشاه، کرمانشاه ایران

4 دانشیار گروه آمار زیستی، دانشکده بهداشت، دانشگاه علوم پزشکی کرمانشاه، کرمانشاه، ایران.

چکیده

زمینه و هدف: تأخیر در درمان علایم روان‌پریشی با افزایش زمان رسیدن به بهبودی، کاهش پاسخ‌دهی به درمان و در نهایت با عود بیشتر اختلال روان‌پریشی همراه است. هدف از این مطالعه تعیین عوامل بالینی مرتبط با تأخیر در درمان اولین علائم روان‌پریشی بیماران مراجعه کننده به بیمارستان فارابی کرمانشاه بود.
مواد و روش‌ها: مطالعه حاضر توصیفی از نوع زمینه‌یابی مقطعی بر روی 94 بیمار شامل 51 مرد و 43 زن با حمله اول روان‌پریشی با استفاده از روش نمونه‌گیری در دسترس صورت گرفت. سپس براساس مصاحبه بالینی برگرفته از چک لیست بالینی تائید شده توسط متخصصین و صاحب‌نظران روان‌پزشکی و روانشناسی تکمیل و داده‌ها از آن استخراج شد و سپس از شاخص‌های آمار توصیفی شامل فراوانی، درصد، میانگین، انحراف معیار، میانه و آزمون t در نرم‌افزار SPSS نسخه 24 جهت خلاصه سازی و تحلیل داده‌ها استفاده گردید.
یافته‌ها: میانگین مدت زمان تأخیر در درمان اولین علایم روان‌پریشی 6/65±5/48 هفته بود. بین متغیر سابقه‌ی مصرف مواد در مراجعین (001/0=P)، سابقه‌ی اختلال اضطرابی (003/0=P)، وجود علایم منفی (001/0=P)، گفتار آشفته (001/0=P)، رفتار آشفته (001/0=P)، با میانگین مدت زمان تأخیر در درمان اولین علایم روان پریشی ارتباط معنی‌داری وجود داشت.
نتیجه‌گیری: عوامل بالینی مرتبط با تأخیر در درمان اولین علایم روان پریشی به عنوان عوامل مهم و تأثیرگذار بر سطح ارتقا سلامت روانی و بهبود کامل افراد مطرح است و شناسایی این عوامل به همراه برنامه‌ریزی مناسب و انجام مداخلات مبتنی بر ارائه خدمات درمانی می‌تواند منجر به ارتقای سلامت روان‌شناختی بیماران شود.

کلیدواژه‌ها

موضوعات


عنوان مقاله [English]

Investigating Clinical Factors Associated with Delay In Treatment Of the First Symptoms Of Psychosis In Patients Referring To Farabi Hospital of Kermanshah

نویسندگان [English]

  • Masoumeh Heidarian 1
  • Hasan Ahadi 2
  • Jalal Shakeri 3
  • Amir Hossein Hashemian 4
1 Department of Health Psychology, Ph.D. Student, Karaj Branch, Islamic Azad University, Karaj, Iran
2 Department of Health Psychology, Professor, Karaj Branch, Islamic Azad University, Karaj, Iran.
3 Department of Psychiatry, Behavioral Sciences Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran
4 Department of Biostatistics, Faculty of Health, Kermanshah University of Medical Sciences, Kermanshah, Iran
چکیده [English]

Aim and background: Delay in treatment of psychotic symptoms is associated with increase in time to recovery, response to treatment, and more relapse rate of psychosis. The purpose of this study is to determine clinical factors associated with delay in treatment of the first symptoms of psychosis in patients referred to Farabi Hospital of Kermanshah.
Materials and methods: This is a descriptive cross-sectional study carried out on 94 patients, 51 male and 43 female, who experienced the first psychotic attack, using available sampling method. Required data are extracted from a clinical interview based on an approved clinical checklist completed by specialists and experts in psychiatry and psychology. Then, descriptive statistics indices including frequency, mean, standard deviation, median, and t-test are summarized and analyzed using SPSS software (version 24).
Findings: mean delay in treatment of the first psychotic symptoms was 48.5±65.6 weeks. There was a significant difference between the patients’ history of drug abuse (P-value=0.001), history of anxiety disorder (P-value=0.003), existence of negative symptoms (P-value=0.001), disorganized speech (P-value=0.001), disorganized behavior (P-value= 0.001), on one hand, and delay in treatment of the first psychotic symptoms, on the other hand.
Conclusion: Clinical factors associated with delay in treatment of the first symptoms of psychosis are introduced as important factors affecting the level of mental health and full recovery of the affected patients; thus, identifying these factors along with proper planning and interventions based on providing health care services can promote the quality of the patients’ psychological well-being.

کلیدواژه‌ها [English]

  • Delay in treatment
  • Psychosis symptoms
  • Clinical factors
[1]. Ran MS, Xiao Y, Chui CH, Hu XZ, Yu YH, Peng MM, Mao WJ, Liu B, Chan EY, Chan CL. Duration of untreated psychosis (DUP) and outcome of people with schizophrenia in rural China: 14-year follow-up study. Psychiatry Research. 2018; 267: 340-5.
[2]. Griswold K, Del Regno PA, Berger RC. Recognition and differential diagnosis of psychosis in primary care. Brain. 2015; 15:100(11): 18-37.
[3]. American psychiatric Association (Diagnostic and Statistical manual) of Mental Disorders. 5th ed. Arjmand publication. 2013; 129-163 [in Persian].
[4]. Kaplan H, Sadock B, Sadock V. Comprehensive text of psychiatry, 10th ED. Arjmand publications. 2013; 817-820 [in Persian].
[5]. Malla AK, Norman RM, Manchanda R, Ahmed MR, Scholten D, Harricharan R, Cortese L, Takhar J. One year outcome in first episode psychosis: influence of DUP and other predictors. Schizophrenia research. 2002; 54(3):231-42.
[6]. World Health Organization. Mental health: new understanding, new hope. The world health report 2001.
[7]. Harris A, Brennan J, Anderson J, Taylor A, Sanbrook M, Fitzgerald D, Lucas S, Redoblado-Hodge A, Gomes L, Gordon E. Clinical profiles, scope and general findings of the Western Sydney First Episode Psychosis Project. Australian and New Zealand Journal of Psychiatry. 2005; 39(1-2):36-43.
[8]. Sanbrook M, Harris A. Evidence for early intervention in first-episode psychosis. The Canadian Journal of Psychiatry. 2004; 49(4):280-1.
 [9]. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of first-episode patients: a systematic review. Archives of general psychiatry. 2005; 62(9):975-83.
[10]. Norman RM, Townsend L, Malla AK. Duration of untreated psychosis and cognitive functioning in first-episode patients. The British Journal of Psychiatry. 2001; 179(4):340-5.
[11]. Drake RJ, Haley CJ, Akhtar S, Lewis SW. Causes and consequences of duration of untreated psychosis in schizophrenia. The British Journal of Psychiatry. 2000; 177(6): 511-5.
[12]. De Haan L, Welborn K, Krikke M, Linszen DH. Opinions of mothers on the first psychotic episode and the start of treatment of their child. European Psychiatry. 2004; 19(4):226-9.
[13]. Harrigan SM, McGorry PD, Krstev H. Does treatment delay in first-episode psychosis really matter?. Psychological medicine. 2003; 33(1): 97-110.
[14]. Casey D, Brown L, Gajwani R, Islam Z, Jasani R, Parsons H, Tah P, Birchwood M, Singh SP. Predictors of engagement in first-episode psychosis. Schizophrenia research. 2016; 175(1-3):204-8.
[15]. Large M, Farooq S, Nielssen O, Slade T. Relationship between gross domestic product and duration of untreated psychosis in low-and middle-income countries. The British Journal of Psychiatry. 2008 Oct; 193(4):272-8.
[16]. Wunderink A, Nienhuis FJ, Systema S, Wiersma D, Treatment delay and response rate in First episode psychosis, Acta psychiatrica Scandinavica. 2006; 113(4): 332-9.
[17]. Addington J, Heinssen RK, Robinson DG, Schooler NR, Marcy P, Brunette MF, Correll CU, Estroff S, Mueser KT, Penn D, Robinson JA. Duration of untreated psychosis in community treatment settings in the United States. Psychiatric Services. 2015; 25: 66(7) :753-6.
[18]. Pek E, Mythily S, Chong SA. Clinical and social correlates of duration of untreated psychosis in first-episode psychosis patients. Annals-academy of medicine singapore. 2006; 35(1):24-6.
[19]. Barnes TR, Leeson VC, Mutsatsa SH, Watt HC, Hutton SB, Joyce EM. Duration of untreated psychosis and social function: 1-year follow-up study of first-episode schizophrenia. The British journal of psychiatry. 2008;1 93(3): 203-9.
[20]. Hongyun QI, Zhang J, Zhenping WA, Haiying MI, Caiying YA, Fuzhen CH, Weizhong FU, Zhang M. Duration of untreated psychosis and clinical outcomes of first-episode schizophrenia: a 4-year follow-up study. Shanghai archives of psychiatry. 2014; 26(1):42.
[21]. Ran MS, Chui CH, Wong IY, Mao WJ, Lin FR, Liu B, Chan CL. Family caregivers and outcome of people with schizophrenia in rural China: 14-year follow-up study. Social psychiatry and psychiatric epidemiology. 2016; 51(4):513-20.
[22]. Gee B, Hodgekins J, Fowler D, Marshall M, Everard L, Lester H, Jones PB, Amos T, Singh SP, Sharma V, Freemantle N. The course of negative symptom in first episode psychosis and the relationship with social recovery. Schizophrenia research. 2016; 174(1-3):165-71.
[23]. Trauelsen AM, Gumley A, Jansen JE, Pedersen MB, Nielsen HG, Trier CH, Haahr UH, Simonsen E. Metacognition in first-episode psychosis and its association with positive and negative symptom profiles. Psychiatry research. 2016; 238:14-23.
[24]. Koutra K, Triliva S, Roumeliotaki T, Stefanakis Z, Basta M, Lionis C, Vgontzas AN. Family functioning in families of first-episode psychosis patients as compared to chronic mentally ill patients and healthy controls. Psychiatry research. 2014; 219(3):486-96.
[25]. Larsen TK, Friis S, Haahr U, Joa I, Johannessen JO, Melle I, Opjordsmoen S, Simonsen E, Vaglum P. Early detection and intervention in first‐episode schizophrenia: a critical review. Acta psychiatrica scandinavica. 2001; 103(5):323-34.
[26]. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-analysis. American Journal of Psychiatry. 2005; 162(10):1785-804.
[27]. Cechnicki A, Cichocki Ł, Kalisz A, Błądziński P, Adamczyk P, Franczyk-Glita J. Duration of untreated psychosis (DUP) and the course of schizophrenia in a 20-year follow-up study. Psychiatry research. 2014; 219(3):420-5.
[28]. Apeldoorn SY, Sterk B, van den Heuvel ER, Schoevers RA, Islam MA, Bruggeman R, Cahn W, de Haan L, Kahn RS, Meijer CJ, Myin-Germeys I. Factors contributing to the duration of untreated psychosis. Schizophrenia Research. 2014; 158(1-3):76-81.
[29]. Pruessner M, Lepage M, Collins DL, Pruessner JC, Joober R, Malla AK. Reduced hippocampal volume and hypothalamus–pituitary–adrenal axis function in first episode psychosis: Evidence for sex differences. NeuroImage: Clinical. 2015; 7:195-202.
[30]. Lappin JM, Morgan KD, Morgan C, Dazzan P, Reichenberg A, Zanelli JW, Fearon P, Jones PB, Lloyd T, Tarrant J, Farrant A. Duration of untreated psychosis and neuropsychological function in first episode psychosis. Schizophrenia research. 2007; 95(1-3):103-10.
[31]. Lieberman JA, Fenton WS. Delayed detection of psychosis: causes, consequences, and effect on public health. American Journal of Psychiatry. 2000; 157(11):1727-30.